Leticia G Leon Selected Research

Leticia G Leon Research Topics

Disease

10	Neoplasms (Cancer) 01/2018 - 01/2011
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 05/2010
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2015 - 07/2010
2	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 12/2011
2	Mesothelioma 12/2016 - 01/2014
2	Adenocarcinoma 01/2012 - 06/2010
1	Carcinoma (Carcinomatosis) 11/2023
1	Adenoma (Adenomas) 11/2023
1	Large Granular Lymphocytic Leukemia 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2020
1	Infections 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Fatigue 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Malignant Mesothelioma 12/2016
1	Hypoxia (Hypoxemia) 12/2016
1	Lung Neoplasms (Lung Cancer) 01/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 12/2011
1	Carcinogenesis 12/2011

Drug/Important Bio-Agent (IBA)

7	Gemcitabine FDA Link 01/2017 - 06/2010
4	Biomarkers (Surrogate Marker)IBA 11/2023 - 05/2010
3	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 12/2011
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2012
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 01/2013
2	Messenger RNA (mRNA)IBA 01/2017 - 12/2016
2	Tyrosine Kinase InhibitorsIBA 12/2015 - 01/2012
2	Gefitinib (Iressa)FDA Link 01/2013 - 01/2012
1	GlucocorticoidsIBA 03/2020
1	ChemokinesIBA 01/2020
1	CytokinesIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	InterferonsIBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	Ataxin-3IBA 01/2018
1	Anaplastic Lymphoma KinaseIBA 01/2018
1	CeramidesIBA 01/2018
1	polyglutamineIBA 01/2018
1	Tryptophan (L-Tryptophan)FDA Link 01/2018
1	CrizotinibIBA 01/2017
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2016
1	Pemetrexed (MTA)FDA Link 01/2014
1	Tubulin ModulatorsIBA 01/2014
1	ARQ 197IBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2013
1	Canertinib (CI 1033)IBA 01/2013
1	DTA0100IBA 10/2012
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 10/2012
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2012
1	RNA (Ribonucleic Acid)IBA 01/2012
1	ParaffinIBA 01/2012
1	Sorafenib (BAY 43-9006)FDA Link 01/2012
1	Sunitinib (Sutent)FDA Link 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 12/2011
1	Epirubicin (Ellence)FDA LinkGeneric 12/2011
1	Docetaxel (Taxotere)FDA Link 12/2011
1	Capecitabine (Xeloda)FDA Link 12/2011
1	Fluorouracil (Carac)FDA LinkGeneric 12/2011
1	Folic Acid AntagonistsIBA 12/2011
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2010
1	Multidrug Resistance-Associated ProteinsIBA 07/2010
1	NucleotidesIBA 07/2010
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 07/2010
1	Deoxycytidine KinaseIBA 07/2010
1	DeoxycytidineIBA 07/2010
1	StaurosporineIBA 07/2010
1	Protein Kinase CIBA 07/2010

Therapy/Procedure

6	Therapeutics 01/2018 - 05/2010
2	Drug Therapy (Chemotherapy) 03/2020 - 01/2012
1	Intra-Arterial Infusions 12/2011
1	Combination Drug Therapy (Combination Chemotherapy) 12/2011